Volume | 65,620 |
|
|||||
News | - | ||||||
Day High | 1.66 | Low High |
|||||
Day Low | 1.58 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
UNITY Biotechnology Inc | UBX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.65 | 1.58 | 1.66 | 1.64 | 1.63 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
650 | 65,620 | $ 1.63 | $ 106,852 | - | 1.4606 - 3.82 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:58:15 | 13 | $ 1.60 | USD |
UNITY Biotechnology Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
24.12M | 14.62M | - | 236k | -59.93M | -4.10 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
UNITY Biotechnology News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical UBX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.60 | 1.66 | 1.52 | 1.58 | 50,431 | -0.02 | -1.25% |
1 Month | 1.78 | 1.94 | 1.50 | 1.65 | 118,457 | -0.20 | -11.24% |
3 Months | 1.93 | 2.02 | 1.50 | 1.73 | 93,412 | -0.35 | -18.13% |
6 Months | 2.42 | 2.47 | 1.50 | 1.80 | 94,782 | -0.84 | -34.71% |
1 Year | 1.95 | 3.82 | 1.4606 | 2.25 | 153,315 | -0.37 | -18.97% |
3 Years | 60.00 | 65.40 | 1.4606 | 13.37 | 752,284 | -58.42 | -97.37% |
5 Years | 81.10 | 154.40 | 1.4606 | 29.01 | 670,700 | -79.52 | -98.05% |
UNITY Biotechnology Description
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. |